NEW YORK (GenomeWeb News) – AutoGenomics, which has filed for an initial public offering, said revenues through the first nine months of the year increased to $14.5 million from $5.2 million a year ago.

For the nine months ended Sept. 30, revenue from consumables sales totaled $13. 2 million, it said in its Form S-1/A filed with the US Securities and Exchange Commission on Thursday. The company added that it expects the majority of revenues to continue to come from genetic test consumable sales "for the foreseeable future."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.